SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
Alcobra Ltd.(NASDAQ : ADHD)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading ADHD News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-3.72%||22.27||3.5%||$556.63m|
|SHPG||Shire PLC Sponsored ADR||1.41%||194.12||0.4%||$261.63m|
|PRGO||Perrigo Co. Plc||0.34%||91.39||3.1%||$161.87m|
|JAZZ||Jazz Pharmaceuticals Plc||-1.21%||150.97||3.1%||$119.12m|
|ENDP||Endo International Plc||-2.96%||17.36||5.6%||$103.08m|
|ICPT||Intercept Pharmaceuticals, Inc.||3.67%||173.03||12.8%||$84.22m|
|UTHR||United Therapeutics Corporation||1.70%||121.01||15.4%||$68.27m|
|SAGE||SAGE Therapeutics, Inc.||0.13%||44.86||8.4%||$61.20m|
|HZNP||Horizon Pharma plc||-1.68%||19.29||11.8%||$60.04m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||0.00%||94.32||7.7%||$45.22m|
Alcobra Ltd. engages in the development and commercialization of proprietary pharmaceutical products for the treatment of central nervous system disorders and cognitive dysfunctions. Its proprietary oral drug candidate, Metadoxine Extended Release, to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.